Skip to main content
BS

Boston Scientific

Boston Scientific designs and manufactures FDA‑cleared medical devices that enable minimally invasive procedures across specialties such as cardiology, electrophysiology, urology, gastroenterology, and neurology. Its portfolio—including catheters, stents, implantable sensors, and drug‑eluting platforms—integrates advanced materials, imaging, and navigation technologies to improve procedural accuracy, reduce complications, and shorten patient recovery. The company also supports clinicians with clinical data, training programs, and 24/7 technical service to streamline adoption and maintain device performance.

Marlborough, United StatesFounded 197954K50K+ followers
Updated 2 months ago

Funding

$1.6B raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Healthcare providers often face limited options for minimally invasive treatments that can safely and effectively address a wide range of complex medical conditions, leading to longer hospital stays, higher complication rates, and increased costs.

Solution

Boston Scientific develops and manufactures a comprehensive portfolio of medical devices designed to enable less invasive procedures across multiple specialties, including cardiology, electrophysiology, urology, gastroenterology, and neurology. The company leverages advanced materials, imaging integration, and precision engineering to create catheters, stents, implantable sensors, and therapeutic delivery systems that improve procedural accuracy and patient outcomes. Its products are supported by extensive clinical evidence, regulatory approvals, and post‑market surveillance to ensure safety and efficacy. Boston Scientific also provides training programs, digital planning tools, and dedicated service teams to help clinicians adopt and maintain these technologies in everyday practice. By streamlining the treatment pathway, the company helps hospitals reduce procedure times, lower complication rates, and shorten patient recovery periods.

Target Audience

Primary customers are hospitals, ambulatory surgery centers, and specialty clinics, as well as physicians and interventional specialists who perform minimally invasive procedures.

Features

  • Wide range of FDA‑cleared devices for cardiovascular, structural heart, electrophysiology, urology, gastrointestinal, pulmonary, and neuro‑interventional procedures
  • Integrated imaging and navigation technologies that enhance real‑time visualization and precision placement of implants
  • Proprietary material coatings and drug‑eluting platforms that improve device durability and therapeutic effectiveness
  • Comprehensive clinical data libraries and evidence‑based guidelines supporting product use
  • Structured physician education, simulation training, and on‑site support programs for rapid adoption
  • Global supply chain and 24/7 technical service infrastructure to ensure device availability and maintenance
This profile is AI-generated and may contain inaccuracies.